TITLE

Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report

AUTHOR(S)
Levy, Hara; Cannon, Carolynn L.; Asher, Daniel; García, Christopher; Cleveland, Robert H.; Pier, Gerald B.; Knowles, Michael R.; Colin, Andrew A.; García, Christopher
PUB. DATE
January 2010
SOURCE
Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Introduction: Mutations in both alleles of the cystic fibrosis transmembrane conductance regulator gene result in the disease cystic fibrosis, which usually manifests as chronic sinopulmonary disease, pancreatic insufficiency, elevated sodium chloride loss in sweat, infertility among men due to agenesis of the vas deferens and other symptoms including liver disease.Case Presentation: We describe a pair of African-American brothers, aged 21 and 27, with cystic fibrosis. They were homozygous for a rare frameshift mutation in the cystic fibrosis transmembrane conductance regulator 3791delC, which would be expected to cause significant morbidity. Although 80% of cystic fibrosis patients are colonized with Pseudomonas aeruginosa by eight years of age, the older brother had no serum opsonic antibody titer to P. aeruginosa by age 13 and therefore would have failed to mount an effective antibody response to the alginate (mucoid polysaccharide) capsule of P. aeruginosa. He was not colonized with P. aeruginosa until 24 years of age. Similarly, the younger brother was not colonized with P. aeruginosa until age 20 and had no significant lung disease.Conclusion: Despite a prevailing idea in cystic fibrosis research that the amount of functional cystic fibrosis transmembrane conductance regulator predicts clinical status, our results indicated that respiratory disease severity in cystic fibrosis exhibits phenotypic heterogeneity. If this heterogeneity is, in part, genetic, it is most likely derived from genes outside the cystic fibrosis transmembrane conductance regulator locus.
ACCESSION #
64934670

 

Related Articles

  • An Unexpected Reprieve. Whitford, Ben // Newsweek (Pacific Edition);9/12/2005 (Pacific Edition), Vol. 146 Issue 11, p48 

    Discusses new treatments for cystic fibrosis (CF) which can extend patients' life spans from months to years and from years to decades. Background on the lethal genetic disorder; The extended life span of today's CF patients which stems not from a single breakthrough but from a stream of minor...

  • An Unexpected Reprieve. Whitford, Ben // Newsweek (Atlantic Edition);9/12/2005 (Atlantic Edition), Vol. 146 Issue 11, p54 

    Discusses new treatments for cystic fibrosis (CF) which can extend patients' life spans from months to years and from years to decades. Background on the lethal genetic disorder; The extended life span of today's CF patients which stems not from a single breakthrough but from a stream of minor...

  • An Unexpected Reprieve. Whitford, Ben // Newsweek;9/12/2005, Vol. 146 Issue 11, p64 

    Discusses new treatments for cystic fibrosis (CF) which can extend patients' life spans from months to years and from years to decades. Background on the lethal genetic disorder; The extended life span of today's CF patients which stems not from a single breakthrough but from a stream of minor...

  • Establishing a diagnosis of cystic fibrosis. Southern, KW; Peckham, D // Chronic Respiratory Disease;2004, Vol. 1 Issue 4, p205 

    Cystic fibrosis (CF) is a recessively inherited condition caused by mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Characterization of the genetic defect has improved understanding of the condition and, in the majority of cases, diagnosis is straightforward....

  • The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis. .Marson, Fernando A. L.; Bertuzzo, Carmen S.; Hortencio, Ta¡s D. R.; Ribeiro, Jos‚ D.; Bonadia, Luciana C.; Ribeiro, Ant“nio F. // BMC Pulmonary Medicine;2012, Vol. 12 Issue 1, p41 

    Background: Cystic Fibrosis (CF) is a monogenic disease with complex expression because of the action of genetic and environmental factors. We investigated whether the ACE gene D/I polymorphism is associated with severity of CF. Methods: A cross-sectional study was performed, from 2009 to 2011,...

  • Gene therapy for children with cystic fibrosis--who has the right to choose? Jaffé, A.; Prasad, S. A.; Larcher, V.; Hart, S. // Journal of Medical Ethics;Jun2006, Vol. 32 Issue 6, p361 

    The article discusses issues related to gene therapy for children with cystic fibrosis (CF). CF is described as a life limiting illness with high morbidity that imposes considerable burdens on children and families. The results of the pathophysiological features of CF are discussed, including...

  • Low Frequency of the ΔF508 Mutation of the CFTR Gene in a Highly Admixed Population in Bahia, Brazil. Moura Costa, Fabiana Maia; Santana, Maria Angélica; Moreira Lemos, Antônio Carlos; Galvão-Castro, Bernardo; Acosta, Angelina Xavier // Human Biology;Jun2007, Vol. 79 Issue 3, p293 

    Cystic fibrosis (CF) is the most common autosomal recessive disease in the European (Caucasian) population, with an incidence of 1:2,000 to 1:8,000. The ΔF508 mutation (66%) is predominant among more than 1,300 different mutations of the CFTR gene. The population of the state of Bahia, in...

  • Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Shead, Elizabeth F.; Haworth, Charles S.; Condliffe, Alison M.; McKeon, Damian J.; Scott, Mike A.; Compston, Juliet E. // Thorax;Jul2007, Vol. 62 Issue 7, p650 

    The article presents information related to expression of cystic fibrosis transmembrane conductance regulator (CFTR) in bone cells. An immunolocalisation of CFTR in human neonatal bone section showed the presence of CFTR expression in osteocytes newly incorporated into bone, whereas more deeply...

  • Gene modifiers in cystic fibrosis. Accurso, Frank J.; Sontag, Marci K. // Journal of Clinical Investigation;Mar2008, Vol. 118 Issue 3, p839 

    Studies of modifier genes in cystic fibrosis (CF) have often been performed in small or narrowly defined populations, leading to conflicting results. In this issue of the JCI, Dorfman et al. demonstrate in a large, population-based study that two previously studied modifier genes, coding for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics